Interleukin-18 is an essential element in host resistance to experimental group B streptococcal disease in neonates.
about
Role of the inflammasome, IL-1β, and IL-18 in bacterial infectionsInflammasome/IL-1β Responses to Streptococcal PathogensBiomarker discovery and development in pediatric critical care medicine.Induction and termination of inflammatory signaling in group B streptococcal sepsis.Natural Killer Cell Functions during the Innate Immune Response to Pathogenic Streptococci.Pathophysiology and treatment of septic shock in neonates.Bacteroides fragilis-derived lipopolysaccharide produces cell activation and lethal toxicity via toll-like receptor 4Essential role of interleukin-1 signaling in host defenses against group B streptococcus.Activation of the NLRP3 inflammasome by group B streptococciSignificance, management and prevention of Streptococcus agalactiae infection during the perinatal period.Group B Streptococcus Induces a Robust IFN-γ Response by CD4(+) T Cells in an In Vitro and In Vivo ModelIdentification of diagnostic biomarkers for infection in premature neonates.TLR-independent type I interferon induction in response to an extracellular bacterial pathogen via intracellular recognition of its DNA.Neonatal Group B Streptococcal Disease in Otherwise Healthy Infants: Failure of Specific Neonatal Immune ResponsesUse of biomarkers in pediatric sepsis: literature review.IL-18 level correlates with development of sepsis in surgical patients.Group B Streptococcal Maternal Colonization and Neonatal Disease: Molecular Mechanisms and Preventative Approaches.
P2860
Q24627445-3E5BD191-F770-45FD-88FC-D77215B6BC15Q26779173-3E735FE9-A71F-4ACD-98E0-16ABC9AA9EE9Q30428168-196D8EDB-0DB5-48D1-ACFF-975BEA76EBB5Q33608933-11852378-89FC-48FD-AE83-0859DB92F36AQ33849846-E556DA80-5EB4-488F-88A3-DA2F3404E0E3Q33940492-A8D33781-C653-40F6-9613-36DDFDF783B7Q34034015-ADADA467-386B-4C15-A468-95EB5C1AADB4Q34197495-E2249615-C9F4-42A9-A06D-14D46F2E39BBQ35740068-13563D39-1015-4C97-8CCF-1ED482A3AFFAQ35917434-70B5E0BD-DB90-46C4-826E-75DCD75AE0B2Q36632936-DDD96D3D-8A8D-4035-8113-F7BFE48CD623Q36919978-27B5DC96-3748-49FD-A325-0FBDB9FC2801Q37055696-D2EF7112-8417-499C-8B8A-6270DF288613Q37683149-2DFAE1A5-A93D-45B9-B757-294144C7C63BQ39093810-5D92193E-D7F1-45F4-AD41-C52A15EA2E9CQ46142715-396283D6-73F3-4BB9-8E86-67715AE94C79Q52665560-53074FD1-833F-4CE9-9E5D-E21DB0B03BF9
P2860
Interleukin-18 is an essential element in host resistance to experimental group B streptococcal disease in neonates.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Interleukin-18 is an essential ...... ptococcal disease in neonates.
@ast
Interleukin-18 is an essential ...... ptococcal disease in neonates.
@en
type
label
Interleukin-18 is an essential ...... ptococcal disease in neonates.
@ast
Interleukin-18 is an essential ...... ptococcal disease in neonates.
@en
prefLabel
Interleukin-18 is an essential ...... ptococcal disease in neonates.
@ast
Interleukin-18 is an essential ...... ptococcal disease in neonates.
@en
P2093
P2860
P1476
Interleukin-18 is an essential ...... eptococcal disease in neonates
@en
P2093
Angelina Midiri
Antonella Bellantoni
Giuseppe De Sossi
Giuseppe Mancuso
Giuseppe Teti
Valentina Valeria Cusumano
Vitaliano Cusumano
P2860
P304
P356
10.1128/IAI.72.1.295-300.2004
P407
P577
2004-01-01T00:00:00Z